K

KinaRx

10 employees

KinaRx is a biotech firm focuses on the development of novel kinase inhibitors for the treatment of Acute myeloid leukemia.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2019

Funding rounds raised

Total raised

$2M

from 1 investors over 1 rounds

K

KinaRx raised $2M on June 3, 2020

Investors: National Cancer Institute

FAQ